MD Medical Group announces dividends for H1 2024 - News — Group of companies "Mother and child"
en
29.08.2024

MD Medical Group (“MD Medical Group”, “MDMG”, "Group" or the "Company"; MOEX: MDMG), a leading Russian private healthcare provider, announces the Board of Directors' decisions, inter alia regarding the payment of interim dividends.

At the meeting held on 28 August 2024, the Company’s Board of Directors reviewed MD Medical Group’s operational and financial results for 6M 2024, assessed the status of ongoing investment projects, and approved the consolidated financial statements for the six months ended 30 June 2024.

In addition to the interim dividends already paid for 3M 2024, the Board decided to distribute dividends for 6M 2024. The dividend will amount to RUB 1.7 billion, or RUB 22 per ordinary share (before tax on income received as dividends), representing a cumulative payout of 61% of the Group's IFRS consolidated net profit for 6M 2024.

The record date for persons entitled to receive dividends will be 9 September 2024 (end of business day).

Dividend payments are scheduled to be made before mid-September.

MDMG CEO Mark Kurtser said:

“The Company has demonstrated robust operational and financial results in H1 2024, with a net profit growth of 45% year-on-year. This sustained, dynamic profit growth, coupled with a manageable level of capital expenditure, enables us to pay dividends exceeding 60% of the period's profit for the second time this year. As per the decision of the Company's Board of Directors, the second part of the 6M dividend will amount to RUB 22 per share of MD Medical Group.

Previously, I had mentioned the Company's commitment to resuming semi-annual dividend payments. We have achieved this goal and will continue to pursue this approach going forward.”


***

About MD Medical Group

MD Medical Group is a leading provider in the Russian private healthcare service market. The Company manages 58 modern healthcare facilities, including 11 hospitals and 47 out-patient clinics in 29 regions of Russia. In 2023, MD Medical Group's revenue amounted to RUB 27.6 bln while EBITDA was RUB 9.2 bln. The Company's ordinary shares are traded on Moscow Exchange (MOEX: MDMG).

Back to news list